Chemed Stock Based Compensation from 2010 to 2025

CHE Stock

USD 612.36 3.19 0.52%

Chemed Corp's Stock Based Compensation is increasing over the years with slightly volatile fluctuation. Overall, Stock Based Compensation is expected to go to about 33.6 M this year. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

1989-03-31

Previous Quarter

-2.1 M

Current Value

8.1 M

Quarterly Volatility

5.5 M

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Chemed Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemed Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 66.2 M, Interest Expense of 3.2 M or Selling General Administrative of 222.6 M, as well as many indicators such as Price To Sales Ratio of 3.44, Dividend Yield of 0.0032 or PTB Ratio of 211. Chemed financial statements analysis is a perfect complement when working with Chemed Corp Valuation or Volatility modules.

Check out the analysis of Chemed Corp Correlation against competitors.

For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.

Latest Chemed Corp's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Chemed Corp over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Chemed Corp's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemed Corp's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Chemed Stock Based Compensation Regression Statistics

	Arithmetic Mean	14,373,691
	Coefficient Of Variation	89.67
	Mean Deviation	11,416,563
	Median	10,868,000
	Standard Deviation	12,888,767
	Sample Variance	166.1T
	Range	33.7M
	R-Value	0.64
	Mean Square Error	105.4T
	R-Squared	0.41
	Significance	0.01
	Slope	1,728,981
	Total Sum of Squares	2491.8T

Chemed Stock Based Compensation History

	2025	33.6 M
	2024	32 M
	2023	30.1 M
	2022	-15.6 K
	2021	31.4 M
	2020	26.8 M
	2019	23.6 M

Other Fundumenentals of Chemed Corp

Stock Based Compensation To Revenue

Chemed Corp Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock
Total Assets		0.26	-0.33	0.97	0.72	0.67	0.73	0.75	-0.13	0.79	0.23	0.7	-0.09	-0.92	0.9	-0.2	0.76	-0.48	0.84	-0.31	0.47	0.62	0.89	0.85	0.6	0.8
Total Stockholder Equity	0.26		0.07	0.13	0.5	0.53	0.54	0.44	-0.02	0.46	0.4	0.53	-0.11	-0.39	0.03	0.29	0.24	-0.33	0.35	0.22	-0.17	0.31	0.17	0.17	-0.01	-0.21
Net Debt	-0.33	0.07		-0.35	-0.18	0.06	0.25	-0.55	0.1	0.07	0.46	0.03	0.46	0.13	-0.28	0.51	-0.61	0.53	-0.2	0.54	-0.68	-0.51	-0.52	-0.23	-0.89	-0.43
Retained Earnings	0.97	0.13	-0.35		0.7	0.55	0.65	0.71	-0.27	0.72	0.17	0.58	-0.06	-0.94	0.97	-0.36	0.77	-0.45	0.87	-0.4	0.52	0.59	0.91	0.89	0.62	0.86
Net Receivables	0.72	0.5	-0.18	0.7		0.78	0.72	0.78	-0.34	0.64	0.28	0.74	-0.03	-0.79	0.63	-0.15	0.55	-0.43	0.87	-0.16	0.54	0.43	0.72	0.72	0.41	0.29
Good Will	0.67	0.53	0.06	0.55	0.78		0.83	0.6	0.08	0.66	0.43	0.96	0.03	-0.66	0.43	0.2	0.37	-0.37	0.7	0.04	0.25	0.38	0.47	0.54	0.13	0.12
Total Liab	0.73	0.54	0.25	0.65	0.72	0.83		0.62	0.06	0.82	0.63	0.76	0.11	-0.81	0.61	0.22	0.35	-0.14	0.78	0.11	0.08	0.46	0.58	0.75	0.06	0.29
Total Current Assets	0.75	0.44	-0.55	0.71	0.78	0.6	0.62		0.02	0.54	0.15	0.52	-0.23	-0.7	0.65	-0.23	0.65	-0.4	0.78	-0.34	0.66	0.71	0.87	0.78	0.75	0.44
Short Term Debt	-0.13	-0.02	0.1	-0.27	-0.34	0.08	0.06	0.02		-0.15	0.0	-0.03	0.14	0.32	-0.28	0.27	-0.4	0.46	-0.35	0.06	-0.13	-0.12	-0.18	-0.19	-0.06	-0.19
Intangible Assets	0.79	0.46	0.07	0.72	0.64	0.66	0.82	0.54	-0.15		0.51	0.61	-0.11	-0.8	0.64	0.16	0.63	-0.46	0.77	0.13	0.02	0.59	0.68	0.75	0.14	0.47
Accounts Payable	0.23	0.4	0.46	0.17	0.28	0.43	0.63	0.15	0.0	0.51		0.39	0.39	-0.38	0.17	0.48	-0.1	0.17	0.32	0.62	-0.25	0.12	0.09	0.3	-0.28	-0.06
Common Stock	0.7	0.53	0.03	0.58	0.74	0.96	0.76	0.52	-0.03	0.61	0.39		0.03	-0.69	0.44	0.18	0.39	-0.42	0.65	0.01	0.22	0.32	0.42	0.46	0.15	0.19
Long Term Debt	-0.09	-0.11	0.46	-0.06	-0.03	0.03	0.11	-0.23	0.14	-0.11	0.39	0.03		0.02	0.03	0.07	-0.49	0.67	-0.12	0.08	-0.07	-0.43	-0.17	-0.05	-0.21	-0.03
Treasury Stock	-0.92	-0.39	0.13	-0.94	-0.79	-0.66	-0.81	-0.7	0.32	-0.8	-0.38	-0.69	0.02		-0.91	0.21	-0.71	0.42	-0.94	0.22	-0.36	-0.57	-0.83	-0.89	-0.43	-0.68
Property Plant Equipment	0.9	0.03	-0.28	0.97	0.63	0.43	0.61	0.65	-0.28	0.64	0.17	0.44	0.03	-0.91		-0.44	0.69	-0.29	0.85	-0.45	0.52	0.51	0.89	0.91	0.59	0.87
Current Deferred Revenue	-0.2	0.29	0.51	-0.36	-0.15	0.2	0.22	-0.23	0.27	0.16	0.48	0.18	0.07	0.21	-0.44		-0.31	0.09	-0.25	0.66	-0.49	0.01	-0.41	-0.26	-0.56	-0.44
Net Tangible Assets	0.76	0.24	-0.61	0.77	0.55	0.37	0.35	0.65	-0.4	0.63	-0.1	0.39	-0.49	-0.71	0.69	-0.31		-0.85	0.73	-0.35	0.4	0.82	0.79	0.69	0.61	0.65
Long Term Debt Total	-0.48	-0.33	0.53	-0.45	-0.43	-0.37	-0.14	-0.4	0.46	-0.46	0.17	-0.42	0.67	0.42	-0.29	0.09	-0.85		-0.49	0.16	-0.22	-0.65	-0.45	-0.31	-0.36	-0.27
Capital Surpluse	0.84	0.35	-0.2	0.87	0.87	0.7	0.78	0.78	-0.35	0.77	0.32	0.65	-0.12	-0.94	0.85	-0.25	0.73	-0.49		-0.24	0.48	0.63	0.86	0.93	0.43	0.53
Deferred Long Term Liab	-0.31	0.22	0.54	-0.4	-0.16	0.04	0.11	-0.34	0.06	0.13	0.62	0.01	0.08	0.22	-0.45	0.66	-0.35	0.16	-0.24		-0.6	-0.14	-0.46	-0.31	-0.64	-0.5
Short Long Term Debt	0.47	-0.17	-0.68	0.52	0.54	0.25	0.08	0.66	-0.13	0.02	-0.25	0.22	-0.07	-0.36	0.52	-0.49	0.4	-0.22	0.48	-0.6		0.26	0.65	0.49	0.82	0.44
Cash And Equivalents	0.62	0.31	-0.51	0.59	0.43	0.38	0.46	0.71	-0.12	0.59	0.12	0.32	-0.43	-0.57	0.51	0.01	0.82	-0.65	0.63	-0.14	0.26		0.69	0.69	0.51	0.44
Net Invested Capital	0.89	0.17	-0.52	0.91	0.72	0.47	0.58	0.87	-0.18	0.68	0.09	0.42	-0.17	-0.83	0.89	-0.41	0.79	-0.45	0.86	-0.46	0.65	0.69		0.92	0.76	0.76
Long Term Investments	0.85	0.17	-0.23	0.89	0.72	0.54	0.75	0.78	-0.19	0.75	0.3	0.46	-0.05	-0.89	0.91	-0.26	0.69	-0.31	0.93	-0.31	0.49	0.69	0.92		0.52	0.68
Net Working Capital	0.6	-0.01	-0.89	0.62	0.41	0.13	0.06	0.75	-0.06	0.14	-0.28	0.15	-0.21	-0.43	0.59	-0.56	0.61	-0.36	0.43	-0.64	0.82	0.51	0.76	0.52		0.67
Capital Stock	0.8	-0.21	-0.43	0.86	0.29	0.12	0.29	0.44	-0.19	0.47	-0.06	0.19	-0.03	-0.68	0.87	-0.44	0.65	-0.27	0.53	-0.5	0.44	0.44	0.76	0.68	0.67

Click cells to compare fundamentals

About Chemed Corp Financial Statements

Chemed Corp stakeholders use historical fundamental indicators, such as Chemed Corp's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Chemed Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chemed Corp's assets and liabilities are reflected in the revenues and expenses on Chemed Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chemed Corp. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Stock Based Compensation	32 M	33.6 M
Stock Based Compensation To Revenue	0.01	0.01

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Chemed Corp is a strong investment it is important to analyze Chemed Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Chemed Corp's future performance. For an informed investment choice regarding Chemed Stock, refer to the following important reports:

How To Invest In Chemed

Details

Is Chemed Stock a good investment?

Details

What is Chemed Corp's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Chemed Corp Correlation against competitors.

For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.

You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemed Corp. If investors know Chemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemed Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.021

Dividend Share

1.8

Earnings Share

19.92

Revenue Per Share

161.827

Quarterly Revenue Growth

0.092

The market value of Chemed Corp is measured differently than its book value, which is the value of Chemed that is recorded on the company's balance sheet. Investors also form their own opinion of Chemed Corp's value that differs from its market value or its book value, called intrinsic value, which is Chemed Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemed Corp's market value can be influenced by many factors that don't directly affect Chemed Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Chemed Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemed Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemed Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Chemed Stock Based Compensation from 2010 to 2025

Latest Chemed Corp's Stock Based Compensation Growth Pattern

Chemed Stock Based Compensation Regression Statistics

Chemed Stock Based Compensation History

Other Fundumenentals of Chemed Corp

Chemed Corp Stock Based Compensation component correlations

About Chemed Corp Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY